Survival of BALB/c mice inoculated with RENCA tumor cells is enhanced when mice are treated with bortezomib before adoptive infusion of syngeneic NK cells. Survival is further improved by depletion of regulatory T cells (Tregs) before bortezomib treatment and NK-cell infusion. Professional illustration by Debra T. Dartez.